Responses

Download PDFPDF

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    The potential effect of dichotomising age (a continuous variable) in multivariate model analysis
    • Abebaw M Yohannes, Senior Lecturer
    • Other Contributors:
      • Connolly MJ, Senior Lecturer, University of Manchester

    Dear Editor

    We have read with great interest, Soler-Catauna and colleagues [1] article that examined, in an impressive prospective study with five years follow-up, factors predicting poor prognosis and mortality in patients with severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Their findings are complimentary with the current available literature in identifying that older age, arteri...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and dis

    Dear Editor,

    The above guidelines will prove useful to rheumatologists or gastroenterologists who will be prescribing these revolutionary drugs for their patients. I, however, have difficulty with algorithm of figure where tuberculin testing comes before risk stratification. For patients with normal chest x-rays and a low risk stratification it will not really matter if their tuberculin test is positive or negativ...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Comments and queries

    Dear Editor,

    Thanks to all concerned for putting together a very useful and long awaited guideline. I have the following questions and comments.

    1. What does "All Patient Rate" in table 3B mean and when should one use it, if at all for UK born patients (say white) as opposed to table 3A?

    Does a UK born white of 75 have a risk of 11 (Table 3A) or 4 (Table 3B - All patient rate column)?

    2. I...

    Show More
    Conflict of Interest:
    None declared.